D. Miller

发表

Interaction of permanently charged chlorpromazine and dopamine analogs with the striatal D-1 dopaminergic receptor.

L. Wallace, R. A. Wallace, M. Harrold, 1989, Biochemical pharmacology.

Synthesis and evaluation of trimetoquinol derivatives: novel thromboxane A2/prostaglandin H2 antagonists with diminished beta-adrenergic agonist activity.

D. Miller, K. Romstedt, D. Feller, 1997, Journal of medicinal chemistry.

Conformation of dopamine at the dopamine receptor.

D. Miller, P. Patil, H. Komiskey, 1978, Proceedings of the National Academy of Sciences of the United States of America.

Identification of an aldose reductase inhibitor site by affinity labeling.

P. Kador, D. Miller, Y. Lee, 1995, Bioorganic & medicinal chemistry.

Effect of the inhibition of dopamine uptake on the dopamine- and dimethyldopamine-induced-inhibition of the potassium-evoked release of [3H]acetylcholine from striatal slices.

T. Farooqui, R. A. Wallace, D. Miller, 1989, General pharmacology.

Sphingosylphosphocholine is a naturally occurring lipid mediator in blood plasma: a possible role in regulating cardiac function via sphingolipid receptors.

L. Pott, D. Baker, K. Liliom, 2001, The Biochemical journal.

Vancomycin pharmacokinetics in normal and morbidly obese subjects

R. Blouin, L. Bauer, D. Miller, 1982, Antimicrobial Agents and Chemotherapy.

Isomeric-activity ratios of trimetoquinol enantiomers on beta-adrenergic receptor subtypes: functional and biochemical studies.

R. Fertel, D. Miller, D. Feller, 1994, Chirality.

beta-Adrenoceptor blocking activity of 1-substituted trimetoquinol analogs.

M. Piascik, D. Miller, D. Feller, 1979, Biochemical pharmacology.

Synthesis and human beta-adrenoceptor activity of 1-(3,5-diiodo-4- methoxybenzyl)-1,2,3,4-tetrahydroisoquinolin-6-ol derivatives in vitro.

Y. He, D. Miller, D. Feller, 2000, Journal of medicinal chemistry.

2-Amino-4-benzyl-4,5,6,7-tetrahydrothiazolo[5,4-c]pyridines: novel selective beta3-adrenoceptor agonists.

D. Miller, D. Feller, S. Vansal, 1999, Journal of medicinal chemistry.

Molecular Cancer apeutics apeutic Discovery 7 , a Novel Antimitotic Indole , Displays a Potent In vitro and Ther ivo Antitumor Activity with Less Neurotoxicity

Charles B. Duke, J. Dalton, Chien-Ming Li, 2010 .

Synthesis and anti-filarial activity of 6-(3-aminophenyl)-2,3,5,6-tetrahydroimidazol[2,1-b]thiazole derivatives

J. Comley, W. Gutteridge, D. Miller, 1992 .

Naturally occurring analogs of lysophosphatidic acid elicit different cellular responses through selective activation of multiple receptor subtypes.

K. Liliom, J. R. Erickson, G. Tigyi, 1998, Molecular pharmacology.

Dimethylthetin can substitute for glycine betaine as an osmoprotectant molecule for Escherichia coli

C. Kunin, D. Miller, S. Chambers, 1987, Journal of bacteriology.

Selective irreversible inhibitors of aldose reductase.

T. Nakayama, H. Itabe, P. Kador, 1992, Journal of medicinal chemistry.

Beta-adrenoceptor subtype activities of trimetoquinol derivatives: biochemical studies on human beta-adrenoceptors expressed in chinese hamster ovary cells.

R. Fertel, D. Miller, D. Feller, 1999, The Journal of pharmacology and experimental therapeutics.

Beta-adrenergic receptor and platelet inhibitory activities of a new series of trimetoquinol and related benzazepine analogs.

D. Miller, K. Romstedt, D. Feller, 1997, General pharmacology.

Interaction of permanently charged metoclopramide analogs with D-2 dopamine receptors.

T. Farooqui, L. Wallace, M. Harrold, 1994, General pharmacology.

Direct quantitative analysis of lysophosphatidic acid molecular species by stable isotope dilution electrospray ionization liquid chromatography-mass spectrometry.

Duane D. Miller, D. Baker, D. Desiderio, 2001, Analytical biochemistry.

Diversity of the pharmacological actions of some tolazoline analogues in human platelets and rat aorta.

D. Miller, D. Feller, P. Patil, 1991, European journal of pharmacology.

Pharmacological properties of novel bicyclic isoquinoline analogs in isolated guinea pig atria, trachea and in human platelets: relationship to trimetoquinol.

V. Roche, A. Adejare, D. Miller, 1991, General pharmacology.

Pharmacologic antagonism of thromboxane A2 receptors by trimetoquinol analogs in vitro and in vivo.

M. Harrold, D. Miller, K. Romstedt, 1991, Chirality.

Characterization of the inhibition of U46619-mediated human platelet activation by the trimetoquinol isomers. Evidence for endoperoxide/thromboxane A2 receptor blockade.

L. Wallace, C. Ahn, D. Miller, 1988, Biochemical pharmacology.

Pharmacological study of atypical beta-adrenoceptors in rat esophageal smooth muscle.

D. Miller, D. Feller, M. Salazar-Bookaman, 1996, European journal of pharmacology.

Pharmacological evaluation of the beta-adrenoceptor agonist and thromboxane receptor blocking properties of 1-benzyl substituted trimetoquinol analogues.

M. Harrold, D. Miller, K. Romstedt, 1990, European journal of pharmacology.

Antagonism of prostaglandin-mediated responses in platelets and vascular smooth muscle by 13-azaprostanoic acid analogs. Evidence for selective blockade of thromboxane A2 responses.

D. Miller, K. Romstedt, D. Feller, 1985, Biochemical pharmacology.

Bronchoselective actions of a new series of trimetoquinol analogues.

D. Miller, D. Feller, J. Chang, 1981, European journal of pharmacology.

Comparative actions of the trimetoquinol, tetrahydropapaveroline and salsolinol isomers in beta-adrenoceptor systems.

D. Miller, D. Feller, R. Venkatraman, 1975, Biochemical pharmacology.

Affinity labeling of the androgen receptor with nonsteroidal chemoaffinity ligands.

Duane D. Miller, J. Dalton, L. Kirkovsky, 1999, Biochemical pharmacology.

Effect of trimetoquinol analogs for antagonism of endoperoxide/thromboxane A2-mediated responses in human platelets and rat aorta.

D. Miller, D. Feller, S. A. Abdel-Aziz, 1985, The Journal of pharmacology and experimental therapeutics.

Synthesis and calpain inhibitory activity of alpha-ketoamides with 2,3-methanoleucine stereoisomers at the P2 position.

I. Donkor, D. Miller, X. Zheng, 2000, Bioorganic & medicinal chemistry letters.

Alpha adrenoreceptors of rabbit aorta and stomach fundus.

W. L. Nelson, D. Miller, P. Patil, 1981, The Journal of pharmacology and experimental therapeutics.

Rapid screening of doping agents in human urine by vacuum MALDI-linear ion trap mass spectrometry.

Hari Kosanam, C. R. Yates, S. Ramagiri, 2007, Analytical chemistry.

Dopaminergic agonists: comparative actions of amine and sulfonium analogues of dopamine.

D. Miller, N. Uretsky, Y. A. Chang, 1984, Journal of medicinal chemistry.

The interactive effects of cocaine/gender on immune function in mice. An observation of in vivo acute cocaine exposure.

D. Miller, W. Boggan, W. Xu, 1997, International journal of immunopharmacology.

Dopaminergic drugs in the cationic form interact with D2 dopamine receptors.

L. Wallace, R. A. Wallace, M. Harrold, 1988, Trends in pharmacological sciences.

Synthesis of halogenated trimetoquinol derivatives and evaluation of their beta-agonist and thromboxane A2 (TXA2) antagonist activities.

G Shams, V. Tantishaiyakul, V Tantishaiyakul, 1992, Journal of medicinal chemistry.

Medetomidine analogs as alpha 2-adrenergic ligands. 2. Design, synthesis, and biological activity of conformationally restricted naphthalene derivatives of medetomidine.

J. Dalton, D. Miller, D. Feller, 1996, Journal of medicinal chemistry.

Microwave-assisted synthesis of medicinally relevant indoles.

D. Miller, S. Patil, R. Patil, 2011, Current medicinal chemistry.

Design and synthesis of enantiomers of 3,5-dinitro-o-tyrosine: alpha-amino-3-hydroxy-5-methyl-4-isoxazolepropanoic acid (AMPA) receptor antagonists.

D. M. Weinstein, L. Wallace, J. Miller, 1998, Journal of medicinal chemistry.

The interaction of ammonium, sulfonium, and sulfide analogues of metoclopramide with the dopamine D2 receptor.

T. Farooqui, M. Harrold, D. Miller, 1993, Journal of medicinal chemistry.

Synthesis and D2 dopaminergic activity of pyrrolidinium, tetrahydrothiophenium, and tetrahydrothiophene analogues of sulpiride.

T. Farooqui, L. Wallace, R. A. Wallace, 1989, Journal of medicinal chemistry.

Tricyclic norephedrine analogs. The isomeric 9-hydroxy-10-amino-1,2,3,4a,9,10,10a-(trans-4a,10a)-octahydrophenanthrenes.

W. L. Nelson, D. Miller, 1970, Journal of medicinal chemistry.

Synthesis and biological evaluation of a tetrahydroisoquinoline derivative possessing selective beta2-adrenergic agonist activity.

P. Kador, D. Miller, D. Feller, 1977, Journal of medicinal chemistry.

Synthesis and alpha-adrenergic activities of 2- and 4-substituted imidazoline and imidazole analogues.

D. Miller, K. Romstedt, D. Feller, 1992, Journal of medicinal chemistry.

Structure-activity relationship of glycine betaine analogs on osmotolerance of enteric bacteria.

M. Ihnat, C. Kunin, D. Miller, 1993, Journal of medicinal chemistry.

Influence of substituted phenethylamines on lipolysis, in vitro. III. Stereoselectivity.

D. Miller, D. Feller, O. Lee, 1974, The Journal of pharmacology and experimental therapeutics.

Synthesis and application of 13C enriched phenylisothiocyanate as a 13C NMR protein probe.

D. Miller, J. Ares, J. Fowble, 1987, Biochemical and biophysical research communications.

Unprecedented crystallization and X-ray crystal structure of racemic N(alpha)-(t-butyloxycarbonyl)-L-L-phenylalanine N-methoxy-N-methylamide.

I. Donkor, D. Miller, C. Ross, 2000, Chirality.

Depolarization of membrane potential and the smooth muscle contraction by isothiocyanatobenzyl imidazoline in guinea-pig stomach circular muscle

J. Jagadeesh, D. Miller, P. Patil, 1999, Naunyn-Schmiedeberg's Archives of Pharmacology.

A novel membrane receptor with high affinity for lysosphingomyelin and sphingosine 1‐phosphate in atrial myocytes.

Duane D. Miller, L. Pott, K. Liliom, 1996, The EMBO journal.

Significance of hydrogen bonding at the S(1)' subsite of calpain I.

I. Donkor, D. Miller, X. Zheng, 2001, Bioorganic & medicinal chemistry letters.

Molecular geometry and adrenergic drug activity.

D. Miller, U. Trendelenburg, P. Patil, 1974, Pharmacological reviews.

Asymmetric synthesis of 2,3-methanoleucine stereoisomers from common intermediates.

I. Donkor, D. Miller, X. Zheng, 2000, Chirality.

Effect of a sulfonium analog of dopamine on the depolarization-induced release of [3H]acetylcholine from mouse striatal slices.

D. Miller, N. Uretsky, B. Turowski, 1984, Biochemical pharmacology.

Synthesis of 1-substituted analogues of trimetoquinol possessing differential and selective beta-adrenergic properties.

D. Miller, D. Feller, R. Raman, 1977, Journal of medicinal chemistry.

Lysophosphatidic acid-induced platelet shape change revealed through LPA1–5 receptor-selective probes and albumin

G. Prestwich, Y. Fujiwara, W. Valentine, 2008, Platelets.

Homology modeling using multiple molecular dynamics simulations and docking studies of the human androgen receptor ligand binding domain bound to testosterone and nonsteroidal ligands.

T. Bishop, J. Dalton, L. Kirkovsky, 2001, Journal of medicinal chemistry.

Effect of 1-methyl-4-phenyl-1,2,3,6 tetrahydropyridine (MPTP) on monoamine neurotransmitters in mouse brain & heart.

Thomas D. Schmittgen, D. Miller, N. Uretsky, 1984, Life sciences.

Effects of the stereochemical orientation of phenethylamines and imidazolines on alpha-adrenergic receptor-mediated DNA synthesis in primary cultured rat hepatocytes.

D. Miller, D. Feller, T. Esbenshade, 1992, Chirality.

Interaction of enantiomers of hydroxy tolazoline with adrenoceptors

D. Miller, P. Patil, J. Sengupta, 1987, Naunyn-Schmiedeberg's Archives of Pharmacology.

Resolution and adrenergic activities of the optical isomers of 4-[1-(1-naphthyl)ethyl]-1H-imidazole.

R. A. Lyon, D. Miller, K. Romstedt, 1992, Chirality.

Alpha adrenergic and histaminergic effects of tolazoline-like imidazolines.

D. Miller, P. Patil, J. Sanders, 1975, The Journal of pharmacology and experimental therapeutics.

Activation of L-type calcium channel by tolazoline derivatives: role of isothiocyanate moiety.

D. Miller, D. Feller, L. Lei, 1998, Journal of cardiovascular pharmacology.

Synthesis and pharmacological evaluation of sulfonium analogues of dopamine: nonclassical dopamine agonists.

D. Miller, N. Uretsky, A. Kuruvilla, 1981, Journal of Medicinal Chemistry.

Effect of permanently charged and uncharged dopaminergic agonists on the potassium-induced release of [3H]acetylcholine from striatal slices.

T. Farooqui, D. Miller, N. Uretsky, 1987, Biochemical pharmacology.

Behavioral effects of a dimethylsulfonium analog of dopamine after injection into the nucleus accumbens and the striatum

D. Miller, N. Uretsky, Y. Chang, 1986, Pharmacology Biochemistry and Behavior.

The isomers of cocaine and tropacocaine: effect on 3H-catecholamine uptake by rat brain synaptosomes.

D. Miller, P. Patil, H. Komiskey, 1977, Life sciences.

N-substituted imidazolines and ethylenediamines and their action on alpha- and beta-adrenergic receptors.

D. Miller, P. Patil, R. Ruffolo, 1985, Journal of medicinal chemistry.

Pharmacological activities of trimetoquinol and 1-benzyl halogen-substituted analogues on rat beta-adrenoceptor subtypes.

R. Fertel, D. Miller, D. Feller, 1996, European journal of pharmacology.

Binding of [3H]dihydroazapetine to alpha-adrenoreceptor-related proteins from rat vas deferens.

R. Ruffolo, D. Miller, P. Patil, 1976, Proceedings of the National Academy of Sciences of the United States of America.

Asymmetric catecholimidazolines and catecholamidines: affinity and efficacy relationships at the alpha adrenoreceptor in rat aorta.

D. Miller, P. Patil, P. Rice, 1987, The Journal of pharmacology and experimental therapeutics.

Halogen-substituted trimetoquinol analogs as thromboxane A2 receptor antagonists in platelets and aorta.

V. Tantishaiyakul, A. Adejare, D. Miller, 1993, Biochemical pharmacology.

Antiplatelet actions of trimetoquinol isomers: evidence for inhibition of a prostaglandin-independent pathway of platelet aggregation.

D. Miller, D. Feller, H. Akbar, 1982, Biochemical pharmacology.

Discovery of nonsteroidal androgens.

Duane D. Miller, J. Dalton, L. Kirkovsky, 1998, Biochemical and biophysical research communications.

Investigation of the effects of phospholipase C on human platelets: evidence that aggregation induced by phospholipase C is independent of prostaglandin generation, released ADP and is modulated by cyclic AMP.

D. Miller, D. Feller, H. Akbar, 1982, Thrombosis research.

Calcium Channel‐Dependent and I1‐Imidazoline Receptor Binding Properties of 2‐(4′‐Isothiocyanatobenzyl) Imidazoline Analogs in Vascular and Brain Tissues fn1

P. Ernsberger, D. Miller, D. Feller, 1995, Annals of the New York Academy of Sciences.

Paradoxical effects of isothiocyanate analog of tolazoline on rat aorta and human platelets.

D. Miller, D. Feller, P. Patil, 1989, Blood & Vessel.

Inhibition of catecholamine uptake by conformationally restricted phenethylamine derivatives.

D. Miller, P. Patil, J. Fowble, 1973, Journal of medicinal chemistry.

Molecular aspects of the receptor activation by imidazolines: an overview.

D. Miller, D. Feller, P. Patil, 1991, Journal of neural transmission. Supplementum.

Enantioselective binding of Casodex to the androgen receptor.

Duane D. Miller, J. Dalton, L. Kirkovsky, 1996, Xenobiotica; the fate of foreign compounds in biological systems.

Chiral nonsteroidal affinity ligands for the androgen receptor. 1. Bicalutamide analogues bearing electrophilic groups in the B aromatic ring.

Duane D. Miller, A. Mukherjee, J. Dalton, 2000, Journal of medicinal chemistry.

Alpha-adrenoceptor-mediated actions of optical isomers and desoxy analogs of catecholimidazoline and norepinephrine in human platelets: in vitro.

C. Ahn, D. Miller, D. Feller, 1986, Biochemical pharmacology.

Kinetics of accumulation, efflux and the pharmacological effects of tritiated dihydroazapetine on the rabbit aorta.

R. Ruffolo, D. Miller, P. Patil, 1977, Journal of Pharmacology and Experimental Therapeutics.

Synthesis and biological activities of a new set of irreversibly acting 2-(4'-isothiocyanatobenzyl)imidazoline analogs in rat thoracic aorta.

D. Miller, D. Feller, P. Patil, 1994, Journal of medicinal chemistry.

Human platelet activation by bacterial phospholipase C is mediated by phosphatidylinositol hydrolysis but not generation of phosphatidic acid: inhibition by a selective inhibitor of phospholipase C.

D. Miller, K. Romstedt, D. Feller, 1984, Thrombosis research.

2-Acetylaminofluorene metabolism in rat liver microsomes: formation of 9-hydroxy-2-acetylaminofluorene and effect of hepatic enzyme modifiers.

D. Miller, D. Feller, J. Fowble, 1979, Toxicology and applied pharmacology.

Biochemical and pharmacological characterization of high-affinity trimetoquinol analogs on guinea pig and human beta adrenergic receptor subtypes: evidence for partial agonism.

R. Fertel, D. Miller, D. Feller, 1994, The Journal of pharmacology and experimental therapeutics.

Optically active derivatives of imidazolines. alpha-Adrenergic blocking properties.

D. Miller, P. Patil, H. Fuder, 1980, Journal of medicinal chemistry.

Stereo-dependent inhibition of human platelet function by the optical isomers of trimetoquinol.

D. Miller, D. Feller, Huzoor-Akbar, 1981, Biochemical pharmacology.

Use of [3H]trimetoquinol as a radioligand in human platelets: interaction with putative endoperoxide/thromboxane A2 receptor sites.

L. Wallace, C. Ahn, D. Miller, 1988, Thrombosis research.

Structure-activity studies of new imidazolines on adrenoceptors of rat aorta and human platelets

V. Tantishaiyakul, D. Miller, K. Romstedt, 1991, Naunyn-Schmiedeberg's Archives of Pharmacology.

Antiallergic effect of trimetoquinol analogs on actively sensitized guinea pig lung tissue, in vitro.

D. Miller, D. Feller, A. Mukhopadhyay, 1986, Biochemical pharmacology.

Effect of aromatic fluorine substitution on the alpha and beta adrenoceptor-mediated effects of 3,4-dihydroxytolazoline in the pithed rat.

R. Ruffolo, A. Adejare, D. Miller, 1989, Journal of Pharmacology and Experimental Therapeutics.

5-fluoro- and 8-fluorotrimetoquinol: selective beta 2-adrenoceptor agonists.

G Shams, A. Adejare, D D Miller, 1987, Journal of medicinal chemistry.

Synthesis and biological evaluation of irreversible inhibitors of aldose reductase.

P. Kador, D. Miller, J. Ares, 1986, Journal of medicinal chemistry.

Pharmacokinetics of S-3-(4-acetylamino-phenoxy)-2-hydroxy-2-methyl-N-(4-nitro- 3-trifluoromethyl-phenyl)-propionamide in rats, a non-steroidal selective androgen receptor modulator

Wei Gao, J. Dalton, D. Miller, 2004, Xenobiotica; the fate of foreign compounds in biological systems.

Differences in the applicability of the easson-stedman hypothesis to the alpha 1- and alpha 2-adrenergic effects of phenethylamines and imidazolines.

R. Ruffolo, D. Miller, P. Patil, 1983, European journal of pharmacology.

Interaction of permanently charged analogs of dopamine with the D-2 dopaminergic receptor.

T. Farooqui, L. Wallace, R. A. Wallace, 1987, Biochemical pharmacology.

Optically active catecholimidazolines: a study of steric interactions at alpha-adrenoreceptors.

G. G. Christoph, J. Gallucci, E. C. Craig, 1983, Journal of Medicinal Chemistry.

Determinants of receptor subtype specificity in the LPA-like lipid mediator family.

J. R. Erickson, G. Tigyi, S. Kobayashi, 1999, Advances in experimental medicine and biology.

Bidirectional allosteric effects of agonists and GTP at alpha(2A/D)-adrenoceptors.

R. Deth, D. Miller, W. Tian, 2000, The Journal of pharmacology and experimental therapeutics.

Epinephrine enantiomers: affinity, efficacy and potency relationships in rat smooth muscle tissues.

D. Miller, P. Patil, P. Rice, 1989, The Journal of pharmacology and experimental therapeutics.

Charged analogues of chlorpromazine as dopamine antagonists.

T. Farooqui, L. Wallace, R. A. Wallace, 1987, Journal of medicinal chemistry.

What is the nature of the charge transfer interaction at the aldose reductase inhibitor site.

T. Nakayama, S. Sato, P. Kador, 1989, Progress in clinical and biological research.

Stereochemical studies of adrenergic drugs. Optically active derivatives of imidazolines.

D. Miller, P. Patil, R. Ruffolo, 1976, Journal of medicinal chemistry.

Biochemical correlates for the pharmacological effects of L(+)-isomers and beta-desoxy-sympathomimetic amines.

R. Ruffolo, D. Miller, P. Patil, 1976, Biochemical pharmacology.

Inhibition of synaptosomal uptake of norepinephrine and dopamine by conformationally restricted sympathomimetic amines.

D. Miller, P. Patil, H. Komiskey, 1978, European journal of pharmacology.

Antagonism by imidazoline-type drugs of muscarinic and other receptors in the guinea-pig ileum.

D. Miller, P. Patil, M. Salazar-Bookaman, 2006, Autonomic & autacoid pharmacology.

Stereoselective inhibition of prostaglandin-induced calcium release from platelet membranes by trimetoquinol.

D. Miller, D. Feller, J. R. Mayo, 1983, Biochemical pharmacology.

1-substituted tetrahydroisoquinoline analogs: beta adrenoceptor blocking agents in the isolated perfused rabbit heart.

M. Piascik, D. Miller, D. Feller, 1979, Life sciences.